Published in Infect Immun on April 28, 2008
Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 5.83
Shiga toxin subtypes display dramatic differences in potency. Infect Immun (2011) 1.63
Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol (2011) 1.42
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) (2010) 1.26
Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev (2014) 1.15
Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun (2009) 1.07
Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS One (2010) 1.06
Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model. PLoS Pathog (2013) 1.04
Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. Microb Pathog (2011) 1.02
Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7. Microbiology (2009) 1.01
A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest (2012) 1.01
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
Correlation between in vivo biofilm formation and virulence gene expression in Escherichia coli O104:H4. PLoS One (2012) 0.98
Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7. Vaccine (2010) 0.97
Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis (2009) 0.96
Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect Immun (2010) 0.93
Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am J Pathol (2008) 0.90
Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model. Infect Immun (2015) 0.84
Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits. Comp Med (2010) 0.82
Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin. Infect Immun (2014) 0.82
Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles. AAPS J (2014) 0.80
Role of Shiga/Vero toxins in pathogenesis. Microbiol Spectr (2014) 0.79
The Pathogenic Potential of Proteus mirabilis is Enhanced by Other Uropathogens During Polymicrobial Urinary Tract Infection. Infect Immun (2016) 0.77
Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes. PLoS One (2015) 0.76
Synchronous Disease Kinetics in a Murine Model for Enterohemorrhagic E. coli Infection Using Food-Borne Inoculation. Front Cell Infect Microbiol (2016) 0.75
Mass Spectrometry-Based Method of Detecting and Distinguishing Type 1 and Type 2 Shiga-Like Toxins in Human Serum. Toxins (Basel) (2015) 0.75
Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7. Vet Pathol (2017) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet (2005) 9.78
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92
Genetic engineering using homologous recombination. Annu Rev Genet (2002) 5.23
Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol (2005) 4.63
Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol (1999) 3.75
Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol (1992) 3.03
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1990) 3.00
Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006. MMWR Morb Mortal Wkly Rep (2006) 2.97
Genomic diversity of enterohemorrhagic Escherichia coli O157 revealed by whole genome PCR scanning. Proc Natl Acad Sci U S A (2002) 2.70
An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med (1999) 2.56
Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun (1993) 2.38
Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology (1994) 2.07
Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons. Infect Immun (1995) 1.93
Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun (2003) 1.81
The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis (1997) 1.79
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect Immun (1994) 1.70
Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun (2005) 1.67
Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A (2006) 1.64
A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol (2006) 1.54
Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun (2004) 1.48
Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J Infect Dis (2000) 1.44
Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun (2005) 1.38
The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression. J Bacteriol (2004) 1.25
Virulence of Shiga toxin-producing Escherichia coli (STEC) in orally-infected mice correlates with the type of toxin produced by the infecting strain. Jpn J Med Sci Biol (1998) 1.20
The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol (2004) 1.19
Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun (2003) 1.12
Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol Lett (2006) 1.09
Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Lett Appl Microbiol (2005) 1.06
Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun (1998) 1.06
Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun (1998) 1.04
Emerging water-borne pathogens. Appl Microbiol Biotechnol (2003) 1.04
Increased oral virulence of Escherichia coli expressing a variant Shiga-like toxin type II operon is associated with both A subunit residues Met4 and Gly102. Microb Pathog (1995) 1.01
Haemolytic uraemic syndrome: an overview. Nephrology (Carlton) (2006) 1.01
Development of a lethal Shiga toxin-producing Escherichia coli-infection mouse model using multiple mitomycin C treatment. Microb Pathog (2003) 0.94
Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. J Med Microbiol (2002) 0.94
Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol (2004) 0.93
Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol Immunol (2003) 0.93
Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol (2006) 0.92
Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can J Microbiol (1998) 0.90
Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome. Clin Exp Immunol (2003) 0.88
Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine model. Microbiol Immunol (2002) 0.83
Induction of glomerular lesions in the kidneys of mice infected with vero toxin-producing Escherichia coli by lipopolysaccharide injection. J Infect Dis (1999) 0.81
Production of shiga toxin by a luxS mutant of Escherichia coli O157:H7 in vivo and in vitro. Microbiol Immunol (2007) 0.81
Characteristic intestinal microflora of specific pathogen-free mice bred in two different colonies and their influence on postnatal murine immunocyte profiles. Exp Anim (2005) 0.80
Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis (2008) 6.21
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis (2012) 4.34
Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A (2012) 3.43
Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing. Nat Biotechnol (2012) 3.39
Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J Bacteriol (2003) 2.54
Type III protein secretion mechanism in mammalian and plant pathogens. Biochim Biophys Acta (2004) 2.44
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7. J Bacteriol (2005) 2.41
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes (2011) 2.37
A salvage pathway for protein structures: tmRNA and trans-translation. Annu Rev Microbiol (2003) 2.13
Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol (2002) 2.13
Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect Immun (2009) 2.07
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc (2013) 2.05
Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol (2005) 2.01
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci U S A (2011) 1.94
Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms. Genome Res (2006) 1.87
A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc Natl Acad Sci U S A (2009) 1.87
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol (2005) 1.84
Cryptic lineages of the genus Escherichia. Appl Environ Microbiol (2009) 1.81
Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun (2012) 1.79
Molecular evolution of typical enteropathogenic Escherichia coli: clonal analysis by multilocus sequence typing and virulence gene allelic profiling. J Bacteriol (2006) 1.76
Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis (2004) 1.73
Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans. Appl Environ Microbiol (2006) 1.71
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70
Genetic diversity and population structure of Escherichia coli isolated from freshwater beaches. Environ Microbiol (2007) 1.69
Evolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun (2004) 1.68
Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun (2005) 1.67
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model. Emerg Infect Dis (2007) 1.62
Relationship between COMLEX and USMLE scores among osteopathic medical students who take both examinations. Teach Learn Med (2010) 1.60
The microbiome of the lung. Transl Res (2012) 1.59
Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect Immun (2009) 1.59
Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes (2010) 1.57
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio (2015) 1.56
Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med (2013) 1.54
Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology (2008) 1.52
Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol (2009) 1.51
Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J Bacteriol (2002) 1.50
Stabilization of the murine gut microbiome following weaning. Gut Microbes (2012) 1.49
Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol Microbiol (2004) 1.48
Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 1.44
Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis (2007) 1.44
Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One (2012) 1.40
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio (2014) 1.40
Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun (2012) 1.36
Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis. J Clin Microbiol (2006) 1.35
Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin-producing clone of pathogenic Escherichia coli. Infect Immun (2002) 1.34
The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33
Genotypic diversity and serotype distribution of group B streptococcus isolated from women before and after delivery. Clin Infect Dis (2008) 1.30
Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes (2011) 1.29
On-chip non-equilibrium dissociation curves and dissociation rate constants as methods to assess specificity of oligonucleotide probes. Nucleic Acids Res (2006) 1.27
The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression. J Bacteriol (2004) 1.25
Application of a neutral community model to assess structuring of the human lung microbiome. MBio (2015) 1.25
Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature. BMC Infect Dis (2008) 1.23
Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One (2013) 1.22
Escherichia albertii in wild and domestic birds. Emerg Infect Dis (2010) 1.22
The biological roles of trans-translation. Curr Opin Microbiol (2002) 1.21
Variation of the natural transformation frequency of Campylobacter jejuni in liquid shake culture. Microbiology (2003) 1.21
Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg Infect Dis (2009) 1.18
Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J Bacteriol (2008) 1.18
A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome (2013) 1.17
A multiresistant clone of Shiga toxin-producing Escherichia coli O118:[H16] is spread in cattle and humans over different European countries. Appl Environ Microbiol (2002) 1.17
Multiple-locus variable-number tandem repeat analysis of Salmonella Enteritidis isolates from human and non-human sources using a single multiplex PCR. FEMS Microbiol Lett (2007) 1.17
Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young girls. Infect Immun (2002) 1.16
Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun (2006) 1.16
Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother (2014) 1.14
The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe (2013) 1.14
Disruption of the human gut microbiota following Norovirus infection. PLoS One (2012) 1.13
Understanding increased mortality in Clostridium difficile-infected older adults. Clin Infect Dis (2013) 1.13
Differential expression of virulence and stress fitness genes between Escherichia coli O157:H7 strains with clinical or bovine-biased genotypes. Appl Environ Microbiol (2009) 1.12
Characterisation of atypical enteropathogenic E. coli strains of clinical origin. BMC Microbiol (2009) 1.11
Global transcriptional response of Escherichia coli O157:H7 to growth transitions in glucose minimal medium. BMC Microbiol (2007) 1.11
DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J Clin Microbiol (2005) 1.11
Enteropathogenic Escherichia coli O157 strains from Brazil. Emerg Infect Dis (2003) 1.10
Mosaic structure and molecular evolution of the leukotoxin operon (lktCABD) in Mannheimia (Pasteurella) haemolytica, Mannheimia glucosida, and Pasteurella trehalosi. J Bacteriol (2002) 1.10
Clostridium difficile and the microbiota. J Clin Invest (2014) 1.09
Ecological succession of bacterial communities during conventionalization of germ-free mice. Appl Environ Microbiol (2012) 1.09
Characterization of the Escherichia coli O157:H7 Sakai GadE regulon. J Bacteriol (2008) 1.09
Clonal structure and variation in virulence of Salmonella enteritidis isolated from mice, chickens, and humans. J AOAC Int (2006) 1.08
Explaining unexplained diarrhea and associating risks and infections. Anim Health Res Rev (2007) 1.08
Genetic differentiation of Escherichia coli O157:H7 clades associated with human disease by real-time PCR. J Clin Microbiol (2008) 1.08
Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun (2011) 1.07
Differentiation of Escherichia coli pathotypes by oligonucleotide spotted array. J Clin Microbiol (2006) 1.07
Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS One (2010) 1.06
Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults. J Am Geriatr Soc (2013) 1.05
Laser capture microdissection and metagenomic analysis of intact mucosa-associated microbial communities of human colon. Appl Microbiol Biotechnol (2010) 1.05
Clostridium difficile ribotype diversity at six health care institutions in the United States. J Clin Microbiol (2013) 1.04
Allelic subtyping of the intimin locus (eae) of pathogenic Escherichia coli by fluorescent RFLP. FEMS Microbiol Lett (2006) 1.04
Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model. PLoS Pathog (2013) 1.04
Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens. J Clin Microbiol (2011) 1.03
Multiple factors interact to produce responses resembling spectrum of human disease in Campylobacter jejuni infected C57BL/6 IL-10-/- mice. BMC Microbiol (2009) 1.03
Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice. Infect Immun (2006) 1.03